| ADC | Antibody-drug conjugate |
| ALL | Acute lymphoblastic leukemia |
| AML | Acute myeloid leukemia |
| BCR | B-cell receptor |
| bsAB | Bispecific antibody |
| CAR | Chimeric antigen receptor |
| CLL | Chronic lymphocytic leukemia |
| CML | Chronic myeloid leukemia |
| DC | Dendritic cell |
| FLT3 | FMS-like tyrosine kinase-3 |
| HLA | Human leukocyte antigen |
| hTERT | Human telomerase reverse transcriptase |
| ITD | Internal tandem duplication |
| LAA | Leukemia-associated antigen |
| LC-MS/MS | Liquid chromatography-coupled tandem mass spectrometry |
| mAB | Monoclonal antibody |
| MDS | Myelodysplastic syndrome |
| NPM1 | Nucleophosmin |
| PRAME | Preferentially expressed antigen of melanoma |
| PD-1 | Programmed death-1 |
| PD-L1 | Programmed death-ligand 1 |
| RHAMM | Receptor for hyaluronan-mediated motility |
| TCR | T-cell receptor |
| TLR | Toll-like receptor |
| TKI | Tyrosine kinase inhibitor |
| WT1 | Wilms’ tumor gene |